AgTech Global International, Inc. Appoints Malcolm A. Leissring as Chief Science Officer Effective January 1, 2022
December 09, 2021 at 01:30 pm
AgTech Global International, Inc. announce the appointment of Dr. Malcolm A. Leissring as its Chief Science Officer (CSO) effective January 1, 2022. This appointment follows Agtechs recent agreement to acquire NooMeds, LLC., a company formed by Dr. Leissring to market A.L.Z. Defense, a scientifically tested dietary supplement shown to prevent memory problems in laboratory models of Alzheimers disease. Dr. Leissring is an award-winning neuroscientist who is internationally recognized for his work on the molecular pathogenesis of Alzheimers disease and diabetes, with an emphasis on drug discovery and development. In his role as CSO of Agtech/Galexxy, Dr. Leissring will help direct the research and drug development program for the novel compounding of psilocybin and cannabidiol (CBD) into proprietary formulations. This program is being conducted by KRTL Biotech, Inc. in South Korea.